Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anbinex in Congenital Antithrombin III Deficiency
NCT00319228Phase 3Terminated
- Sponsor
- Grifols
- Start
- Apr 2008
- Primary completion
- Dec 2011
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of Anbinex in congenital antithrombin III deficiency, sponsored by Grifols. Started Apr 2008; status: terminated.
02
Drugs
Anbinex
03
Conditions
congenital antithrombin III deficiency
Beyond the preview
Go deeper on NCT00319228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00319228.